Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model

S. C. Song, Y. M. An, J. H. Shin, M. J. Chung, J. G. Seo, Eungbin KIm

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Patients with metabolic disorders frequently suffer from side effects induced by long-term oral medications. The present study using a rat model system indicated that leflunomide (LF) and amlodipine (AMD), the active ingredients contained in the medications for rheumatoid arthritis and hypertension, respectively, appeared to induce various bowel problems including constipation and inflammation. In the small and large intestine, LF increased the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 compared to the null control and AMD increased the expression of both TNF-α and IL-1β, although its effect on IL-6 was only increased in the large intestine. It is noteworthy that the probiotic blend tested was found to alleviate intestinal complications caused by LF and AMD. Analysis of the gut microbiota revealed that AMD induced compositional changes in the gut microbiota. Namely, members of the phylum Bacteroidetes, which constituted only about 0.3% of the microbiota in the null control, made up more than 10% of the total composition in the AMD-administered rats. Interestingly, the probiotic blend was also found to normaliSe the gut microbiota.

Original languageEnglish
Pages (from-to)801-808
Number of pages8
JournalBeneficial Microbes
Volume8
Issue number5
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

leflunomide
Amlodipine
Probiotics
Large Intestine
Interleukin-1
Interleukin-6
Tumor Necrosis Factor-alpha
Bacteroidetes
Microbiota
Constipation
Small Intestine
Rheumatoid Arthritis
Hypertension
Inflammation

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Microbiology (medical)

Cite this

Song, S. C. ; An, Y. M. ; Shin, J. H. ; Chung, M. J. ; Seo, J. G. ; KIm, Eungbin. / Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model. In: Beneficial Microbes. 2017 ; Vol. 8, No. 5. pp. 801-808.
@article{7cf9fb75d84d4e7d9e9d251d3e1c5946,
title = "Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model",
abstract = "Patients with metabolic disorders frequently suffer from side effects induced by long-term oral medications. The present study using a rat model system indicated that leflunomide (LF) and amlodipine (AMD), the active ingredients contained in the medications for rheumatoid arthritis and hypertension, respectively, appeared to induce various bowel problems including constipation and inflammation. In the small and large intestine, LF increased the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 compared to the null control and AMD increased the expression of both TNF-α and IL-1β, although its effect on IL-6 was only increased in the large intestine. It is noteworthy that the probiotic blend tested was found to alleviate intestinal complications caused by LF and AMD. Analysis of the gut microbiota revealed that AMD induced compositional changes in the gut microbiota. Namely, members of the phylum Bacteroidetes, which constituted only about 0.3{\%} of the microbiota in the null control, made up more than 10{\%} of the total composition in the AMD-administered rats. Interestingly, the probiotic blend was also found to normaliSe the gut microbiota.",
author = "Song, {S. C.} and An, {Y. M.} and Shin, {J. H.} and Chung, {M. J.} and Seo, {J. G.} and Eungbin KIm",
year = "2017",
month = "1",
day = "1",
doi = "10.3920/BM2016.0231",
language = "English",
volume = "8",
pages = "801--808",
journal = "Beneficial microbes",
issn = "1876-2883",
publisher = "Wageningen Academic Publishers",
number = "5",

}

Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model. / Song, S. C.; An, Y. M.; Shin, J. H.; Chung, M. J.; Seo, J. G.; KIm, Eungbin.

In: Beneficial Microbes, Vol. 8, No. 5, 01.01.2017, p. 801-808.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Beneficial effects of a probiotic blend on gastrointestinal side effects induced by leflunomide and amlodipine in a rat model

AU - Song, S. C.

AU - An, Y. M.

AU - Shin, J. H.

AU - Chung, M. J.

AU - Seo, J. G.

AU - KIm, Eungbin

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Patients with metabolic disorders frequently suffer from side effects induced by long-term oral medications. The present study using a rat model system indicated that leflunomide (LF) and amlodipine (AMD), the active ingredients contained in the medications for rheumatoid arthritis and hypertension, respectively, appeared to induce various bowel problems including constipation and inflammation. In the small and large intestine, LF increased the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 compared to the null control and AMD increased the expression of both TNF-α and IL-1β, although its effect on IL-6 was only increased in the large intestine. It is noteworthy that the probiotic blend tested was found to alleviate intestinal complications caused by LF and AMD. Analysis of the gut microbiota revealed that AMD induced compositional changes in the gut microbiota. Namely, members of the phylum Bacteroidetes, which constituted only about 0.3% of the microbiota in the null control, made up more than 10% of the total composition in the AMD-administered rats. Interestingly, the probiotic blend was also found to normaliSe the gut microbiota.

AB - Patients with metabolic disorders frequently suffer from side effects induced by long-term oral medications. The present study using a rat model system indicated that leflunomide (LF) and amlodipine (AMD), the active ingredients contained in the medications for rheumatoid arthritis and hypertension, respectively, appeared to induce various bowel problems including constipation and inflammation. In the small and large intestine, LF increased the expression of tumour necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 compared to the null control and AMD increased the expression of both TNF-α and IL-1β, although its effect on IL-6 was only increased in the large intestine. It is noteworthy that the probiotic blend tested was found to alleviate intestinal complications caused by LF and AMD. Analysis of the gut microbiota revealed that AMD induced compositional changes in the gut microbiota. Namely, members of the phylum Bacteroidetes, which constituted only about 0.3% of the microbiota in the null control, made up more than 10% of the total composition in the AMD-administered rats. Interestingly, the probiotic blend was also found to normaliSe the gut microbiota.

UR - http://www.scopus.com/inward/record.url?scp=85031406270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031406270&partnerID=8YFLogxK

U2 - 10.3920/BM2016.0231

DO - 10.3920/BM2016.0231

M3 - Article

VL - 8

SP - 801

EP - 808

JO - Beneficial microbes

JF - Beneficial microbes

SN - 1876-2883

IS - 5

ER -